Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism ITK inhibitors(Tyrosine-protein kinase ITK/TSK inhibitors), RLK inhibitors(TXK tyrosine kinase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC28H35F2N5O2S |
InChIKeyNXTKFBGDLDPFLB-PKOBYXMFSA-N |
CAS Registry1575818-46-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Autoimmune Diseases | Preclinical | US | 06 Dec 2014 | |
Inflammation | Preclinical | US | 06 Dec 2014 | |
Neoplasms | Preclinical | US | 06 Dec 2014 |